MYC and neoplasm: As expected, ENZ/IR combination resulted in much greater inhibition of Myc-CaP tumor growth compared with ENZ or IR treatment alone and, importantly, cotreatment of anti–PD-1 antibody with ENZ and IR further decreased tumor growth, although anti–PD-1 antibody alone had little or no effect on tumor growth (Figure 7, A–D).